Current Status of Prescription in Type 2 Diabetic Patients from General Hospitals in Busan.
10.4093/dmj.2014.38.3.230
- Author:
Ji Hye SUK
1
;
Chang Won LEE
;
Sung Pyo SON
;
Min Cheol KIM
;
Jun Hyeob AHN
;
Kwang Jae LEE
;
Ja Young PARK
;
Sun Hye SHIN
;
Min Jeong KWON
;
Sang Soo KIM
;
Bo Hyun KIM
;
Soon Hee LEE
;
Jeong Hyun PARK
;
In Joo KIM
Author Information
1. Division of Endocrinology and Metabolism, Department of Internal Medicine, Woori Medical Clinic, Busan, Korea.
- Publication Type:Multicenter Study ; Original Article
- Keywords:
Diabetes mellitus, type 2;
Drug therapy;
Hospitals, general
- MeSH:
Aspirin;
Blood Pressure;
Busan;
Cardiovascular Diseases;
Cohort Studies;
Demography;
Diabetes Mellitus, Type 2;
Diet;
Drug Therapy;
Hospitals, General*;
Humans;
Hydroxymethylglutaryl-CoA Reductase Inhibitors;
Hypertension;
Hypoglycemic Agents;
Insulin;
Korea;
Platelet Aggregation Inhibitors;
Prescriptions*;
Prevalence;
Prospective Studies;
Pulse Wave Analysis
- From:Diabetes & Metabolism Journal
2014;38(3):230-239
- CountryRepublic of Korea
- Language:English
-
Abstract:
BACKGROUND: Data regarding the prescription status of individuals with diabetes are limited. This study was an analysis of participants from the relationship between cardiovascular disease and brachial-ankle pulse wave velocity in patients with type 2 diabetes (REBOUND) Study, which was a prospective multicenter cohort study recruited from eight general hospitals in Busan, Korea. We performed this study to investigate the current status of prescription in Korean type 2 diabetic patients. METHODS: Type 2 diabetic patients aged 30 years or more were recruited and data were collected for demographics, medical history, medications, blood pressure, and laboratory tests. RESULTS: Three thousands and fifty-eight type 2 diabetic patients were recruited. Mean age, duration of diabetes, and HbA1c were 59 years, 7.6 years, and 7.2%, respectively. Prevalence of hypertension was 66%. Overall, 7.3% of patients were treated with diet and exercise only, 68.2% with oral hypoglycemic agents (OHAs) only, 5.3% with insulin only, and 19.2% with both insulin and OHA. The percentage of patients using antihypertensive, antidyslipidemic, antiplatelet agents was similar as about 60%. The prevalence of statins and aspirin users was 52% and 32%, respectively. CONCLUSION: In our study, two thirds of type 2 diabetic patients were treated with OHA only, and one fifth with insulin plus OHA, and 5% with insulin only. More than half of the patients were using each of antihypertensive, antidyslipidemic, or antiplatelet agents. About a half of the patients were treated with statins and one third were treated with aspirin.
